Challenges of BDNF-based therapies: From common to rare diseases
- 30 November 2020
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 162, 105281
- https://doi.org/10.1016/j.phrs.2020.105281
Abstract
No abstract availableThis publication has 234 references indexed in Scilit:
- Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro StudyPLOS ONE, 2013
- Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injuryBiomaterials, 2012
- Enhancement of LTP in Aged Rats is Dependent on Endogenous BDNFNeuropsychopharmacology, 2011
- Understanding proneurotrophin actions: Recent advances and challengesDevelopmental Neurobiology, 2010
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavoneProceedings of the National Academy of Sciences of the United States of America, 2010
- Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutationsNeurobiology of Disease, 2009
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Distinct Role of Long 3′ UTR BDNF mRNA in Spine Morphology and Synaptic Plasticity in Hippocampal NeuronsCell, 2008
- Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promotersGenomics, 2007